LATEST NEWS:

Q&A with Riccardo Palmisano, MolMed CEO, and Finanzaonline's forum members November 19, 2019 - 12:44 La Stampa: Nasce la cura con l'antigene: il merito è dell'universo biotech October 22, 2019 - 13:45 MF: BIOTECH, VERSO UN NUOVO PRIMATO. Italia leader nella farmaceutica se agevolerà le imprese di R&S October 18, 2019 - 10:51 24 settembre 2019 - Sanità24: Biotech week, per le Lifescience la parola d'ordine è "fare sistema" September 24, 2019 - 18:39 24 settembre 2019 - Il Sole 24 Ore in occasione della European Biotech Week fa un punto sull'Italia del biotech e dedica un focus al campus OpenZone September 24, 2019 - 10:25

Pipeline

Novel autologous and allogeneic therapies in pre-clinical and clinical stage for the treatament of cancer (hematological and solid tumors) and rare diseases.

GMP Solutions

Tailor made GMP services for your cell and gene therapy projects, including viral vector manufacturing and cell engineering.

Stock information

Discover More

Video

Video intervista a Riccardo Palmisano, CEO di MolMed, che risponde agli utenti di Finanzaonline

8 AGOSTO 2019, MolMed ospite di SuperQuark, che dedica un servizio al biotech italiano nell’ambito dei CAR T

MolMed Company presentation at MESA 2019*

* Please note: this Company presentation has been made before Zalmoxis' CMA withdrawal on October 10th, 2019

All videos

Subscribe to press releases

By subscribing to this newsletter, you confirm that you have read the Privacy Policy and agree to receive MolMed's press releases